Vancouver's biotech industry is experiencing a significant boom, with companies like Aspect Biosystems and Gandeeva Therapeutics at the forefront. Aspect Biosystems CEO, Tamer Mohamed, aims to build a $100B company in Vancouver, emphasizing the city's potential as a life sciences capital. The support from institutions like UBCmedicine and the BC life sciences community is driving the growth of biotech companies in British Columbia, positioning the region as a key player in the global life sciences sector.
British life sciences are a beacon of hope with the power to transform lives, but to realise their full potential, the public and private sectors must work together Says @griffitha https://t.co/FEx4RFWHWN
Today in @globeandmail, the British Columbia’s biotech scene is booming, and with the unwavering support of @UBCmedicine and the BC life sciences community, Gandeeva Therapeutics is growing along with it. https://t.co/oNF4Unuj4r
Today in @globeandmail, British Columbia’s biotech scene is booming, and with the support of @UBCmedicine and the BC life sciences community, Gandeeva Therapeutics is growing along with it. https://t.co/oNF4Unuj4r
Vancouver’s biotech scene is one of the most promising innovation clusters in the country. But can the local sector grow into a prosperous global life sciences hub - and avoid the fate of past stars like Angiotech and QLT? My cover story from this weekend: https://t.co/pdDlQGF3wu https://t.co/ura5O5ZMHR
“I want to build a $100B company, but it has to be here, it can be here, and it will be here” - Tamer Mohamed, Aspect Biosystems CEO, who is determined to turn Vancouver into a life sciences capital. From my weekend feature on the city’s biotech boom https://t.co/pdDlQGF3wu
B.C. biotech boom: Vancouver looks to join the global big leagues of modern medicine https://t.co/2meNTLHnLq